(Q50515497)

English

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy

scientific article published in December 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

0 references

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

author name string

Murdoch DR

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

McDonagh TA

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

Byrne J

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

Blue L

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

Farmer R

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

Morton JJ

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

Dargie HJ

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

138

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

6 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

1126-1132

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Severity of heart failure and dosage of angiotensin converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Sustained Hemodynamic Efficacy of Therapy Tailored to Reduce Filling Pressures in Survivors With Advanced Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Biochemical detection of left-ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

A microassay for active and total renin concentration in human plasma based on antibody trapping

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Measurement of plasma angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Some statistical methods useful in circulation research.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Effect of ACE inhibitors on the atrial natriuretic peptides in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970079-7

7 January 2021

Identifiers

10.1016/S0002-8703(99)70079-7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

release_gsx5xlur7febtcysdcgn3jvevq

1 reference

https://api.fatcat.wiki/v0/release/gsx5xlur7febtcysdcgn3jvevq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10577444

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50515497&oldid=2251877815"